Curcuminoid compounds show promise against COVID-19 in neuronal cells

FHS
May 14, 2024
11:18 am

The effects of curcumin and curcuminoids on a human neuroblastoma cell line (SH-SY5Y) infected with SARS-CoV-2.

Where Oak HC/FT investor Nancy Brown is placing her bets on AI in health tech

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 23, 2024

Idorsia’s Tryvio deal delay; Galectin’s liver drug disappoints

Plus, news about Pyxis, Epitopea and Genevant: Idorsia’s deal for blood pressure drug hits snag: The Swiss company Sign up to read this article for

December 21, 2024

Lonza looks to buy facilities and tech to boost service offerings

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 30, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.